Abstract: The invention relates to a solid orodispersible pharmaceutical composition of agomelatine, characterised in that it comprises agomelatine and granules consisting of co-dried lactose and starch.

Abstract: A self-reversible invert latex having a crosslinked cationic polyelectrolyte, formed by the copolymerization of at least one cationic monomer with at least one neutral monomer and at least one nonionic surfactant monomer.

Abstract: A composition and process of preparation of emulsifier agents based on an alkylpolyglycoside structure with a length of alkyl chain having from 6 to 12 carbon atoms to be used. The resulting emulsions exhibit an excellent dispersion of the fillers and/or pigments without it being necessary to add coemulsifier or dispersant. The emulsifier makes it possible, by itself alone, to prevent the reagglomeration of the fillers and/or pigments.

Abstract: A composition, method of preparation1 and use to enhance the cosmetic feel of oil-in-water emulsions based upon the addition to the oil in water emulsion of one or more alkylpolyxylosides represented by formula: R—O—(X)p, wherein p is a decimal number between 1 and 5, wherein X is a xylose residue, and wherein R is a branched alkyl radical represented by the formula: CH(CnH2n+1)(CmH2m+1)—CH2— wherein m is an integer between 6 and 12, n is an integer between 8 and 16, and the sum of m+n is in the range of from about 14 to 26.

Abstract: A composition and process of preparation of emulsifier agents based on an alkylpolyglycoside structure with a length of alkyl chain having from 6 to 12 carbon atoms to be used. The resulting emulsions exhibit an excellent dispersion of the fillers and/or pigments without it being necessary to add coemulsifier or dispersant. The emulsifier makes it possible, by itself alone, to prevent the reagglomeration of the fillers and/or pigments.

Abstract: The present invention relates to a pharmaceutical composition for the administration, by the nasal route, of piribedil in solution or in powder form.

Abstract: The invention relates to a solid orodispersible pharmaceutical composition of an antithrombotic compound (compound A), characterised in that it comprises compound A or a pharmaceutically acceptable salt thereof and granules consisting of co-dried lactose and starch.

Abstract: A composition and method for a linear or crosslinked cationic polyelectrolyte, involving copolymerization of at least one cationic monomer with at least one neutral monomer and at least one-nonionic surfactant monomer.

Abstract: The invention concerns novel polyol-glycoside compositions for topical use. The invention is characterized in that said compositions contain an efficient amount of polyol-glycoside obtained by acetalization of a polyol of formula (I), wherein n is an integer equal to 2, 3 or 4; or of formula (II), wherein m is an integer equal to 2 or 3, with a reducing sugar. The invention is applicable in cosmetics, dermopharmaceutics, pharmaceutics, textile industry.

Abstract: A composition and method for a linear or crosslinked cationic polyelectrolyte, involving copolymerization of at least one cationic monomer with at least one neutral monomer and at least one nonionic surfactant monomer.

Abstract: Composition, characterized in that it comprises: from 0.5% to 100% by weight of a compound of formula (I): in which R1, R2, R3 and R4 represent a hydrogen atom, a methyl radical or an ethyl radical, n and m represent a number between 0 and 10, it being understood that the sum n+m is greater than zero, and from 0% to 99.5% by weight of a compound of formula (II): in which R5, R6, R7 and R8 represent a hydrogen atom, a methyl radical or an ethyl radical, p and q, which are identical or different, represent a number between 0 and 10, it being understood that the sum p+q is greater than zero. Use as chain extender in polyurethane elastomer formulations and/or as monomers in the preparation of saturated or unsaturated polyesters, of polycarbonates or of epoxy resins.

Abstract: The invention relates to a solid orodispersible pharmaceutical composition of agomelatine, characterised in that it comprises agomelatine and granules consisting of co-dried lactose and starch.

Abstract: The invention relates to a solid orodispersible pharmaceutical composition of perindopril, characterised in that it comprises perindopril or a pharmaceutically acceptable salt thereof and granules consisting of co-dried lactose and starch.

Abstract: The invention relates to a solid orodispersible pharmaceutical composition of ivabradine, characterised in that it comprises ivabradine or a pharmaceutically acceptable salt thereof and granules consisting of co-dried lactose and starch.

Abstract: The invention relates to a solid orodispersible pharmaceutical composition of piribedil, characterised in that it comprises piribedil, or a pharmaceutically acceptable salt thereof, and granules consisting of co-dried lactose and starch.

Abstract: A composition and process of preparation of emulsifier agents based on an alkylpolyglycoside structure with a length of alkyl chain having from 6 to 12 carbon atoms to be used. The resulting emulsions exhibit an excellent dispersion of the fillers and/or pigments without it being necessary to add coemulsifier or dispersant. The emulsifier makes it possible, by itself alone, to prevent the reagglomeration of the fillers and/or pigments.

Abstract: Linear or crosslinked cationic polyelectrolyte, characterized in that it is obtained by copolymerization of at least one cationic monomer with at least one neutral monomer and at least one nonionic surfactant monomer, self-reversible invert latex; their use as a thickener for cosmetic or pharmaceutical compositions, as a thickener for printing pastes for the textile industry, as a thickener for industrial or household detergents, as additives for the assisted recovery of petroleum, as a rheology modifier for drilling mud.

Abstract: The present invention relates to a new solid controlled-release pharmaceutical composition obtained by thermoforming, in the hot state, a mixture based on polymers belonging to the polymethacrylate family and perindopril or a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to a new solid controlled-release pharmaceutical composition obtained by thermoforming, in the hot state, a mixture based on polymers belonging to the polymethacrylate family and ivabradine or a pharmaceutically acceptable salt thereof.

Abstract: Novel compounds of formula (I): RO—(X)p  (I) in which p represents a decimal number between 1 and 5, x represents a xylose residue, and R represents a radical: CH(CnH2n+1)(CmH2m+1)—CH2— in which m is an integer between 6 and 18, n is an integer between 4 and 18 and the sum n+m is greater than or equal to 10. Process for preparing them, compositions containing them and their use as surfactants.